معرفی
Steven Banik is Assistant Professor at Stanford University's Department of Chemistry, with affiliations including Bio-X, Wu Tsai Human Performance Alliance, and Sarafan ChEM-H. His research combines chemical biology, protein engineering, and molecular design to develop therapeutic strategies for aging-related disorders, cancer, and metabolic diseases.
- PhD in Chemistry (2017), Harvard University
- B.S. in Chemistry (2011), University of Wisconsin–Madison
- NIH/Burroughs Postdoctoral Fellow in Chemical Biology at Stanford
Research Focus: Developing biochemical tools to rewire mammalian biology through synthetic molecules. Key projects include:
- LYTACs for extracellular protein degradation
- TRAMs for protein relocalization
- Metabolite-based obesity therapies (Lac-Phe, BHB-amino acids)
- Molecular glues for interactome reorganization
- CRISPR-based proximity screening
Publication Trends: 2021-2024 works span lysosomal targeting chimeras (LYTACs, TRAFTACs), metabolite signaling pathways, protein relocalization strategies, and molecular glue discovery. His work bridges chemical synthesis with therapeutic applications in obesity, cancer, and neurodegenerative diseases.
Awards:
- 2023 Moore Inventor Fellow
Academic Leadership: Advises 28 graduate/undergraduate researchers across Stanford departments. Current projects focus on molecular design for disease intervention and pharmacokinetic optimization.
